Of 13 patients receiving MTX as their main treatment, respectively comedication for psoriasis, 15.4% (n=2) failed to achieve seroconversion and of 16 patients receiving a TNF-α inhibitor as their main treatment for psoriasis 12.5% (n=2) did not reach seroconversion. This evidence concerns the gene TNF and psoriasis.